US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Filana Therapeutics

0.7910

-0.0247-3.03%

Volume:140.55K

Turnover:110.40K

Market Cap:38.21M

PE:-0.90

High:0.8079

Open:0.8016

Low:0.7750

Close:0.8157

52wk High:4.98

52wk Low:0.6701

Shares:48.31M

Float Shares:46.92M

Volume Ratio:0.36

T/O Rate:0.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.8752

EPS(LYR):-1.8836

ROE:-55.78%

ROA:-7.14%

PB:0.60

PE(LYR):-0.42

Loading ...

Overview Company News Filings

Filana Therapeutics CEO Makes Bold Insider Move That Could Signal Big Upside

Filana Therapeutics CEO Richard Barry Acquires USD 78,196 of Common Shares

Pepsi Stock Sits Near 52-Week Low as JPMorgan Downgrades Ratings, What's Driving the Move?

U.S. Stocks on the MOVE-Greenland Mines, GameStop, Shopify

NASDAQ Trade Halt Volatility Trading Pause at 10:42 Am

Filana can proceed with study as hold lifted, says Lucid Capital

Filana Therapeutics Shares Jump 35% to $1 Premarket After FDA Lifts Clinical Hold on Co's Epilepsy Drug

THOMSON REUTERS

Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam

Filana Therapeutics Plans Phase 2a Simufilam Trial in TSC-Related Epilepsy After FDA Lifts Clinical Hold

Filana Therapeutics, - Subjects Eligible for 48-Week Extension Study After Double-Blind Phase

THOMSON REUTERS

Filana Therapeutics, - Patient Screening for Phase 2a Study Expected to Begin by Q1 2027

THOMSON REUTERS

Filana Therapeutics, - FDA Lifts Clinical Hold on Filana's Simufilam for Tsc-Related Epilepsy

THOMSON REUTERS

Filana Therapeutics, - Phase 2a Study to Enroll 40 Subjects at 13 U.S. Sites over 16 Weeks

THOMSON REUTERS

NASDAQ Trade Halt Halt News Pending at 07:55 Am

Filana Therapeutics Receives NASDAQ Notice for Sub-$1 Minimum Bid Price Noncompliance

OncoZenge to Present BupiZenge Phase III Program at Pain Therapeutics Summit

Ensysce Biosciences to Present at Cantor Global Healthcare Conference

Filana Therapeutics Q2 EPS $(0.18) Beats $(0.23) Estimate

Benzinga Earnings

Filana Therapeutics Q2 FY26 Net Loss Narrows 80.55% to $8.6 Million

Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/FLNA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FLNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FLNA\",,,,,undefined,":{"symbol":"FLNA","market":"US","secType":"STK","nameCN":"Filana Therapeutics","latestPrice":0.791,"timestamp":1791472589715,"preClose":0.8157,"halted":0,"volume":140552,"delay":0,"changeRate":-0.03028074046830936,"floatShares":46917646,"shares":48307896,"eps":-0.875208,"marketStatus":"Trading","change":-0.0247,"latestTime":"10-08 11:17:59 EDT","open":0.8016,"high":0.8079,"low":0.775,"amount":110400.73717232,"amplitude":0.040333,"askPrice":0.791,"askSize":200,"bidPrice":0.7821,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.875208,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.8157,"preHourTrading":{"tag":"盘前","latestPrice":0.808,"preClose":0.8157,"latestTime":"09:27 EDT","volume":1526,"amount":1235.6180704,"timestamp":1791466052286,"change":-0.0077,"changeRate":-0.00944,"amplitude":0.024519},"postHourTrading":{"tag":"盘后","latestPrice":0.8,"preClose":0.8157,"latestTime":"19:52 EDT","volume":6983,"amount":5707.483,"timestamp":1791417173227,"change":-0.0157,"changeRate":-0.019247,"amplitude":0.024519},"volumeRatio":0.364193,"impliedVol":0.6993,"impliedVolPercentile":0.2313},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FLNA\",,,,,undefined,":{"symbol":"FLNA","floatShares":46917646,"roa":"-7.14%","roe":"-55.78%","lyrEps":-1.883615,"volumeRatio":0.364193,"shares":48307896,"dividePrice":0,"high":0.8079,"amplitude":0.040333,"preClose":0.8157,"low":0.775,"week52Low":0.6701,"pbRate":"0.60","week52High":4.98,"institutionHeld":0.3169,"latestPrice":0.791,"committee":0.428571,"eps":-0.875208,"divideRate":0,"volume":140552,"delay":0,"ttmEps":-0.875208,"open":0.8016,"prevYearClose":1.98,"prevWeekClose":0.9309,"prevMonthClose":0.886,"prevQuarterClose":0.886,"fiveDayClose":0.965,"twentyDayClose":0.8089,"sixtyDayClose":1.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FLNA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-29","symbol":"FLNA","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785297600000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2026-05-07","symbol":"FLNA","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.21},{"market":"US","date":"2026-03-12","symbol":"FLNA","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"pre","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FLNA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FLNA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1779854400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FLNA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FLNA","date":"2026-10-07","current":-0.903785,"percent":0.223776,"low":-1.176848,"twenty":-1.020544,"median":-0.882864,"eighty":-0.756545,"high":-0.548743,"avg":-0.884699,"sd":0.14116,"marketCap":42264578},"quantilePoints":[{"date":"2026-03-13","current":-1.035476,"twenty":-1.018822,"median":-0.993842,"eighty":-0.968861,"marketCap":94200397},{"date":"2026-03-20","current":-0.971755,"twenty":-1.052469,"median":-1.035476,"eighty":-0.980251,"marketCap":88403449},{"date":"2026-03-27","current":-0.939894,"twenty":-1.035476,"median":-0.99034,"eighty":-0.956117,"marketCap":85504975},{"date":"2026-04-02","current":-0.913343,"twenty":-1.035476,"median":-0.971755,"eighty":-0.913343,"marketCap":83089581},{"date":"2026-04-10","current":-0.913343,"twenty":-1.014236,"median":-0.950514,"eighty":-0.897413,"marketCap":83089581},{"date":"2026-04-17","current":-0.934584,"twenty":-0.998305,"median":-0.926619,"eighty":-0.886793,"marketCap":85021896},{"date":"2026-04-24","current":-0.881482,"twenty":-0.982375,"median":-0.918653,"eighty":-0.886793,"marketCap":80191107},{"date":"2026-05-01","current":-0.76997,"twenty":-0.971755,"median":-0.908033,"eighty":-0.860242,"marketCap":70046449},{"date":"2026-05-08","current":-0.722178,"twenty":-0.971755,"median":-0.897413,"eighty":-0.828381,"marketCap":65698738},{"date":"2026-05-15","current":-0.768948,"twenty":-0.952207,"median":-0.889448,"eighty":-0.793752,"marketCap":59901791},{"date":"2026-05-22","current":-0.799954,"twenty":-0.950514,"median":-0.881482,"eighty":-0.768948,"marketCap":62317185},{"date":"2026-05-29","current":-0.961185,"twenty":-0.950853,"median":-0.881482,"eighty":-0.769766,"marketCap":74877238},{"date":"2026-06-05","current":-0.868167,"twenty":-0.950853,"median":-0.884138,"eighty":-0.774113,"marketCap":67631054},{"date":"2026-06-12","current":-0.812356,"twenty":-0.942018,"median":-0.880569,"eighty":-0.790031,"marketCap":63283343},{"date":"2026-06-18","current":-0.750344,"twenty":-0.936708,"median":-0.870862,"eighty":-0.769561,"marketCap":58452554},{"date":"2026-06-26","current":-0.719338,"twenty":-0.931941,"median":-0.860242,"eighty":-0.763894,"marketCap":56037159},{"date":"2026-07-02","current":-0.775149,"twenty":-0.929817,"median":-0.854932,"eighty":-0.756545,"marketCap":60384870},{"date":"2026-07-10","current":-0.737942,"twenty":-0.927155,"median":-0.843362,"eighty":-0.756545,"marketCap":57486396},{"date":"2026-07-17","current":-0.669729,"twenty":-0.921847,"median":-0.823469,"eighty":-0.744143,"marketCap":52172527},{"date":"2026-07-24","current":-0.578075,"twenty":-0.918653,"median":-0.812356,"eighty":-0.737942,"marketCap":45032620},{"date":"2026-07-31","current":-1.096868,"twenty":-0.922912,"median":-0.812356,"eighty":-0.737942,"marketCap":46375580},{"date":"2026-08-07","current":-1.095725,"twenty":-0.938832,"median":-0.823469,"eighty":-0.737942,"marketCap":46327272},{"date":"2026-08-14","current":-1.080758,"twenty":-0.959945,"median":-0.843362,"eighty":-0.739037,"marketCap":45694438},{"date":"2026-08-21","current":-1.076873,"twenty":-0.988871,"median":-0.854932,"eighty":-0.743564,"marketCap":45530191},{"date":"2026-08-28","current":-1.054593,"twenty":-1.016358,"median":-0.860242,"eighty":-0.744143,"marketCap":44588188},{"date":"2026-09-04","current":-0.946391,"twenty":-1.024201,"median":-0.872615,"eighty":-0.744143,"marketCap":40013430},{"date":"2026-09-11","current":-0.924226,"twenty":-1.016888,"median":-0.881026,"eighty":-0.744143,"marketCap":39076257},{"date":"2026-09-18","current":-0.822651,"twenty":-1.014236,"median":-0.874368,"eighty":-0.750344,"marketCap":34781685},{"date":"2026-09-25","current":-0.882979,"twenty":-1.014236,"median":-0.877468,"eighty":-0.750344,"marketCap":37332342},{"date":"2026-10-02","current":-1.102581,"twenty":-1.016888,"median":-0.881482,"eighty":-0.756545,"marketCap":46617119},{"date":"2026-10-07","current":-0.999635,"twenty":-1.020544,"median":-0.882864,"eighty":-0.756545,"marketCap":42264578}],"updateTime":1791472679735},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FLNA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672386796","title":"Filana Therapeutics CEO Makes Bold Insider Move That Could Signal Big Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2672386796","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672386796?lang=en_us&edition=fundamental","pubTime":"2026-10-02 10:02","pubTimestamp":1790906563,"startTime":"0","endTime":"0","summary":"New insider activity at Filana Therapeutics ( ($FLNA) ) has taken place on October 1, 2026. President & CEO Richard Barry has significantly increas...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/filana-therapeutics-ceo-makes-bold-insider-move-that-could-signal-big-upside-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/filana-therapeutics-ceo-makes-bold-insider-move-that-could-signal-big-upside-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","FLNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782891","title":"Filana Therapeutics CEO Richard Barry Acquires USD 78,196 of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782891","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782891?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:04","pubTimestamp":1790798671,"startTime":"0","endTime":"0","summary":"Filana Therapeutics CEO Richard Barry acquires USD 78,196 of common sharesFilana Therapeutics President and CEO Richard Barry reported an open-market purchase of 93,091 common shares at $0.84.Holdings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL2tj49Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Filana Therapeutics CEO Richard Barry Acquires USD 78,196 of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","FLNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121372937","title":"Pepsi Stock Sits Near 52-Week Low as JPMorgan Downgrades Ratings, What's Driving the Move?","url":"https://stock-news.laohu8.com/highlight/detail?id=1121372937","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121372937?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:30","pubTimestamp":1790677835,"startTime":"0","endTime":"0","summary":"Even though PepsiCo (PEP) shares are hovering near their 52-week low, analysts at JPMorgan clearly do not see this as an appealing buying opportunity.JPMorgan analyst Andrea Teixeira downgraded...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN8TJ469.HKD","PEP","LU1894683348.USD","BK4504","BK4588","LU0098860793.USD","BK4177","LU0234572021.USD","BK4585","LU1244550494.USD","IE000WAW04H5.SGD","IE000BZT7R73.USD","IE00BBT3K403.USD","IE0000B7K699.USD","IE000F7OJYX1.SGD","LU1244550221.USD","BK4550","BK4533","IE000MB6IJN5.SGD","LU1894683264.USD","IE00B3T34201.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","BK4581","BK4007","FLNA","BK4534","LU0320765646.SGD","LU1162221912.USD","LU1244550577.SGD","LU1929549753.HKD","BK4566","FTXG","IE000SO60NU8.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669237741","title":"U.S. Stocks on the MOVE-Greenland Mines, GameStop, Shopify","url":"https://stock-news.laohu8.com/highlight/detail?id=2669237741","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669237741?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:41","pubTimestamp":1790091697,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, ShopifySeptember 22 (Reuters)-The tech-heavy Nasdaq hit an intraday record high for the first time since early June on Tuesday, underpinned by s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL6N45E0HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VICR","KMI","FLNA","RIOT","RJF","THO","CMPX","VRTX","SCHW","SF","ZEO","GME","MLKN","CLDX","AMGN","DCOY","CXT","DAVA","MARA","BFLY","CONY","SOS","CW","AZO","GEMI","AMP","COIN","ODDS","USNG","OKE","SHOP","SHPU","VLO","EPD","HUT","GOOGL","ONON","HUBC","VKTX","RSI","BTTC","ET","GRML","DNA","MPWR","MRNA","SLXN","LEN","EAF","MSFT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669116128","title":"NASDAQ Trade Halt Volatility Trading Pause at 10:42 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2669116128","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669116128?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:42","pubTimestamp":1790088156,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 10:42 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nAQN2MKBGF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","FLNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669140714","title":"Filana can proceed with study as hold lifted, says Lucid Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2669140714","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669140714?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:05","pubTimestamp":1790085948,"startTime":"0","endTime":"0","summary":"Lucid Capital analyst Elemer Piros reiterates a Buy rating on Filana Therapeutics (FLNA) with an $8 price target after the company said the FDA has...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/filana-can-proceed-with-study-as-hold-lifted-says-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/filana-can-proceed-with-study-as-hold-lifted-says-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCIZ","FLNA","BK4555","BK4099","LABU","BK4007","LCID","BK4551","BK4596","BK4588","BK4585","LCDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142563","title":"Filana Therapeutics Shares Jump 35% to $1 Premarket After FDA Lifts Clinical Hold on Co's Epilepsy Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142563","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142563?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:53","pubTimestamp":1790081612,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E0U4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FLNA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669442921","title":"Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam","url":"https://stock-news.laohu8.com/highlight/detail?id=2669442921","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669442921?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:20","pubTimestamp":1790079649,"startTime":"0","endTime":"0","summary":"Filana Therapeutics (FLNA) announced that the U.S. Food and Drug Administration, FDA, has lifted the clinical hold on the Company’s investigational...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/filana-therapeutics-announces-u-s-fda-lifted-clinical-hold-on-simufilam-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/filana-therapeutics-announces-u-s-fda-lifted-clinical-hold-on-simufilam-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","IBB","BK4585","LABU","BK4588","BK4007","FLNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669114141","title":"Filana Therapeutics Plans Phase 2a Simufilam Trial in TSC-Related Epilepsy After FDA Lifts Clinical Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2669114141","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669114141?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:04","pubTimestamp":1790078686,"startTime":"0","endTime":"0","summary":"Filana Therapeutics plans Phase 2a simufilam trial in TSC-related epilepsy after FDA lifts clinical holdFilana Therapeutics cleared to restart simufilam development in TSC-related epilepsy after the F","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL3CJrmM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","FLNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669419681","title":"Filana Therapeutics, - Subjects Eligible for 48-Week Extension Study After Double-Blind Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2669419681","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669419681?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUAS7GVN:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FLNA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669419531","title":"Filana Therapeutics, - Patient Screening for Phase 2a Study Expected to Begin by Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669419531","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669419531?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUAS7GVN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FLNA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141969","title":"Filana Therapeutics, - FDA Lifts Clinical Hold on Filana's Simufilam for Tsc-Related Epilepsy","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141969","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141969?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUAS7GVN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FLNA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141933","title":"Filana Therapeutics, - Phase 2a Study to Enroll 40 Subjects at 13 U.S. Sites over 16 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141933?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUAS7GVN:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","FLNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141530","title":"NASDAQ Trade Halt Halt News Pending at 07:55 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141530","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141530?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:55","pubTimestamp":1790078100,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTHALT NEWS PENDING AT 07:55 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nAQN2MK9IL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","FLNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668733199","title":"Filana Therapeutics Receives NASDAQ Notice for Sub-$1 Minimum Bid Price Noncompliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2668733199","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668733199?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:16","pubTimestamp":1789762596,"startTime":"0","endTime":"0","summary":"Filana Therapeutics receives Nasdaq notice for sub-$1 minimum bid price noncomplianceNasdaq flagged Filana Therapeutics for noncompliance with the $1 minimum bid-price rule after 30 straight business ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL5Yc4rl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","FLNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390926","title":"OncoZenge to Present BupiZenge Phase III Program at Pain Therapeutics Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390926","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390926?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:17","pubTimestamp":1788769025,"startTime":"0","endTime":"0","summary":"OncoZenge to present BupiZenge Phase III program at Pain Therapeutics SummitOncoZenge will present its Phase III BupiZenge program at the Pain Therapeutics Summit on Sept. 28-29 in the San Francisco B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL7W4GJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","FLNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664425811","title":"Ensysce Biosciences to Present at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664425811","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664425811?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:32","pubTimestamp":1788352370,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences to present at Cantor Global Healthcare ConferenceEnsysce will present at the 2026 Cantor Global Healthcare Conference in New York on September 10 at 9:10 a.m. ET.Management plans t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbw8Nkj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ENSC","FLNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655860857","title":"Filana Therapeutics Q2 EPS $(0.18) Beats $(0.23) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655860857","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655860857?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:04","pubTimestamp":1785326668,"startTime":"0","endTime":"0","summary":"Filana Therapeutics (NASDAQ:FLNA) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.23) by 18.18 percent. This is a 80.43 percent increase over losses of $(0.92) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60756874/filana-therapeutics-q2-eps-0-18-beats-0-23-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655867047","title":"Filana Therapeutics Q2 FY26 Net Loss Narrows 80.55% to $8.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655867047","media":"Reuters","labels":["policyRegulatory","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655867047?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:04","pubTimestamp":1785326647,"startTime":"0","endTime":"0","summary":"Filana Therapeutics Q2 FY26 net loss narrows 80.55% to $8.6 millionFilana Therapeutics posted a GAAP net loss of USD 8.6 million, or USD 0.18 per share, in Q2 2026, narrowing from USD 44.2 million.R&D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL6BRZbp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLNA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655672148","title":"Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2655672148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655672148?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:00","pubTimestamp":1785326402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA5LS1PT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","FLNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":33,"code":"91000000","status":"200"}]}}